Cargando…

Significance of CDKN2A gene A148T variant in patients with bladder cancer

OBJECTIVES: The A148T polymorphism of CDKN2A gene is observed in various neoplasms with the incidence rate of 3-35%, however, rather little is known either about the frequency of its occurrence or of its significance in urinary bladder carcinoma. MATERIALS AND METHODS: DNA was isolated from blood of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Borkowska, Edyta, Jędrzejczyk, Adam, Kruk, Andrzej, Pietrusiński, Michał, Traczyk, Magdalena, Rożniecki, Marek, Kałużewski, Bogdan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Polish Urological Association 2011
Materias:	Basic Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3921733/ https://www.ncbi.nlm.nih.gov/pubmed/24578887 http://dx.doi.org/10.5173/ceju.2011.03.art17

Ejemplares similares

Detection of loss of heterozygosity in patients with urinary bladder carcinoma: neoplastic tissue vs. urine sediment cells
por: Traczyk, Magdalena, et al.
Publicado: (2011)

The A148T variant of CDKN2A gene in bladder cancer
por: Borkowska, E, et al.
Publicado: (2011)

Polymorphic variants of H-RAS protooncogene and their possible role in bladder cancer etiology
por: Traczyk, Magdalena, et al.
Publicado: (2012)

Artificial neural network in predicting bladder cancer recurrence
por: Borkowska, Edyta, et al.
Publicado: (2012)

Molecular subtyping of bladder cancer using Kohonen self-organizing maps
por: Borkowska, Edyta M, et al.
Publicado: (2014)

The prevalence of CHEK2 and CYP1B1 mutations/polymorphisms in urinary bladder cancer
por: Banaszkiewicz, Monika, et al.
Publicado: (2012)

Concomitance of oncogenic HPV types, CHEK2 gene mutations, and CYP1B1 gene polymorphism as an increased risk factor for malignancy
por: Banaszkiewicz, Monika, et al.
Publicado: (2013)

EORTC risk tables – their usefulness in the assessment of recurrence and progression risk in non–muscle–invasive bladder cancer in Polish patients
por: Borkowska, Edyta M., et al.
Publicado: (2013)

The role of selected egzo- and endogenic agents on preinitiation process of bladder cancer
por: Iwaniuk, A, et al.
Publicado: (2015)

The Usefulness of Cell-Based and Liquid-Based Urine Tests in Clarifying the Diagnosis and Monitoring the Course of Urothelial Carcinoma. Identification of Novel, Potentially Actionable, RB1 and ERBB2 Somatic Mutations
por: Kałużewski, Tadeusz, et al.
Publicado: (2021)

MicroRNAs Which Can Prognosticate Aggressiveness of Bladder Cancer
por: Borkowska, Edyta Marta, et al.
Publicado: (2019)

Urine miRNA as a potential biomarker for bladder cancer detection – a meta-analysis
por: Kutwin, Piotr, et al.
Publicado: (2018)

Primary liver injury and delayed resolution of liver stiffness after alcohol detoxification in heavy drinkers with the PNPLA3 variant I148M
por: Rausch, Vanessa, et al.
Publicado: (2016)

HIF-1, GLUT1, endoglin, and BIRC5 expression in urine samples obtained from patients with bladder malignancies – after photodynamic diagnosis (PDD)
por: Markowski, Michał, et al.
Publicado: (2012)

Bladder cancer survival in patients with NOD2 or CDKN2A variants
por: Złowocka-Perłowska, Elżbieta, et al.
Publicado: (2022)

Genotypic and Phenotypic Changes in Candida albicans as a Result of Cold Plasma Treatment
por: Tyczkowska-Sieroń, Ewa, et al.
Publicado: (2020)

Functional CDKN2A assay identifies frequent deleterious alleles misclassified as variants of uncertain significance
por: Kimura, Hirokazu, et al.
Publicado: (2022)

Analysis of sequence variants in the 3'UTR of CDKN2A gene in melanoma patients
por: Przybyła, Anna, et al.
Publicado: (2015)

Silencing expression of the NANOG gene and changes in migration and metastasis of urinary bladder cancer cells
por: Gawlik-Rzemieniewska, Natalia, et al.
Publicado: (2015)

Altered Secretory Activity of APE1/Ref-1 D148E Variants Identified in Human Patients With Bladder Cancer
por: Lee, Yu Ran, et al.
Publicado: (2016)

Novel germline variants of CDKN1B and CDKN2C identified during screening for familial primary hyperparathyroidism
por: Mazarico-Altisent, I., et al.
Publicado: (2022)

Association Study of Genetic Variants in CDKN2A/CDKN2B Genes/Loci with Late-Onset Alzheimer's Disease
por: Tedde, Andrea, et al.
Publicado: (2011)

Incidence and Predictors of Clinically Significant Bleedings after Transcatheter Left Atrial Appendage Closure
por: Zieliński, Kamil, et al.
Publicado: (2022)

Origins of the Coronary Arteries and Their Significance
por: Joshi, Subhash D., et al.
Publicado: (2010)

Quantitative anatomy of the growing abdominal aorta in human fetuses: An anatomical, digital and statistical study
por: Szpinda, Michał, et al.
Publicado: (2012)

Clinicopathological Significance of CDKN2A Promoter Hypermethylation Frequency with Pancreatic Cancer
por: Tang, Bo, et al.
Publicado: (2015)

From GWAS variant to function: A study of ∼148,000 variants for blood cell traits
por: Sun, Quan, et al.
Publicado: (2021)

Report on the Effect of the Implementation of an Early Detection and Prevention of Cancer Program on Families at High Hereditary Risk—Concentrating on Patients Undergoing Genetic Diagnostics and Counseling in Central Poland
por: Kałużewski, Tadeusz, et al.
Publicado: (2023)

Neural stem/progenitor cells circulating in peripheral blood of patients with neovascular form of AMD: a novel view on pathophysiology
por: Machalińska, Anna, et al.
Publicado: (2011)

Detection and significance of human papillomavirus, CDKN2A (p16) and CDKN1A (p21) expression in squamous cell carcinoma of the larynx
por: Chernock, Rebecca D., et al.
Publicado: (2012)

Textural entropy as a potential feature for quantitative assessment of jaw bone healing process
por: Kołaciński, Michał, et al.
Publicado: (2015)

Clinical significance of promoter region hypermethylation of microRNA-148a in gastrointestinal cancers
por: Sun, Jingxu, et al.
Publicado: (2014)

Decreased expression and clinical significance of miR-148a in hepatocellular carcinoma tissues
por: Pan, Linjiang, et al.
Publicado: (2014)

Predictive values of Notch signalling in renal carcinoma
por: Jędroszka, Dorota, et al.
Publicado: (2017)

Polymorphisms of NRF2 and NRF2 target genes in urinary bladder cancer patients
por: Reszka, Edyta, et al.
Publicado: (2014)

CDKN3 Overcomes Bladder Cancer Cisplatin Resistance via LDHA-Dependent Glycolysis Reprogramming
por: Li, Mengxuan, et al.
Publicado: (2022)

Regulation of Huntingtin Gene Expression by miRNA-137, -214, -148a, and Their Respective isomiRs
por: Kozlowska, Emilia, et al.
Publicado: (2013)

Ki-67 Expression as a Predictive Factor of Muscle Invasion in Bladder Cancer
por: Warli, Syah Mirsya, et al.
Publicado: (2018)

Increased IL-1α expression is correlated with bladder cancer malignant progression
por: Yao, Shi-Jie, et al.
Publicado: (2020)

Clinicopathological significance of overexpression of interleukin-6 in colorectal cancer
por: Zeng, Jun, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_7b4eepso0tsheminl902gi5o6l